Fulgent Genetics Inc expected to post a loss of 32 cents a share - Earnings Preview

Fulgent Genetics

01/05/2024 14:54

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 3 for
the period ending March 31 2024
    * The El Monte California-based  company is expected to
report a
1.2% decrease in revenue to $65.363 million from $66.17 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Fulgent Genetics Inc is
for a
loss of 32 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $25.00​, above​ its last closing price of $20.35. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.28       -0.29      0.28      Beat    197.7
 Sep. 30 2023  -0.35       -0.33      -0.39     Missed  -18.2
 Jun. 30 2023  -0.33       -0.33      -0.08     Beat    75.6​
 Mar. 31 2023  -0.43       -0.43      -0.22     Beat    48.4
 ​​Dec.        -0.56       -0.56      -0.48     Beat    14.3
 31 2022                                                
 Sep. 30 2022  0.05        0.05       0.32      Beat    498.1​
 Jun. 30 2022  0.73        0.73       0.78      Beat    6.8
 Mar. 31 2022  3.84        3.86       5.08      Beat    31.6
 This summary was machine generated May 1 at 13:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)